Ardelyx, Inc. · 8 hours ago
Executive Director, Quality Operations
Ardelyx, Inc. is a publicly traded commercial biopharmaceutical company focused on developing innovative medicines for unmet medical needs. The Executive Director of Quality Operations will lead all aspects of Quality Operations, ensuring compliance and overseeing quality processes for product development and commercialization.
BiotechnologyHealth CareMedical
Responsibilities
Demonstrate a primary commitment to patient safety and product quality by maintaining compliance to Ardelyx Quality Policies and procedures
Support the development of a proactive quality systems culture throughout the business
Establish a high-performing team to drive organizational goals & objectives and instill a robust quality culture
Drive engagement to ensure personnel have clear expectations, appropriate tools and information, and opportunity to share, grow and develop and team members are recognized for their contributions
Ensure adequate and compliant investigations into OOT/OOS results generated at contract test labs
Ensure compliance with applicable post market requirements for annual stability testing of designated batches as per commitment to regulatory agency
Partner with Technical Operations and Regulatory Affairs on development projects, method and process transfer/optimization and validation program requirements
Establish data trending programs across products to proactively identify and investigate trends and report trending outcomes at Quality Management Review and other forums
Drive systemic process change as a result of deviations/investigations and other quality trends
Help define department objectives to align with corporate goals
Keep management informed on product quality and other concerns such as supplier Quality issues, deviations
Assure appropriate systems and processes are in place for assessing product impact, investigation, follow up and closure of deviations and audit observations
Sponsor quality and technical projects with third party suppliers; collaborating with internal stakeholders and GxP partners to facilitate resolution of quality and technical issues
Evaluate and approve compliance documentation including regulatory filings for Ardelyx products
Collaborate with Ardelyx international business partners as needed
Develop budget forecasts and track QA expenses
Qualification
Required
Bachelor's degree with 15+ years of related experience, preferably in life sciences with a minimum of ten years of Quality Assurance and Analytical experience in development and commercial programs
Must have strong expertise in US FDA regulations and guidance with a strong emphasis on compliance and direct experience with regulatory submissions
Strong analytical skills including trend and statistical analysis
Demonstrated ability to communicate and interact with all levels of the organization including Executive Leadership
Strong interpersonal skills to provide coaching, training, and direction
Proven experience influencing across the organization to improve product or processes
Proven ability to identify Quality issues/discrepancies through a risk-based approach and effectively and proactively resolve the issues/discrepancies in a diplomatic, flexible and constructive manner
Knowledge of Regulations, 21CFR 210/211, ICH Guidelines
Must be able to manage shifting priorities to meet critical deadlines in a fast paced and dynamic environment
Must have strong written and communication skills
Ability to travel domestically and internationally up to 15%
Preferred
Experience with hosting, leading and managing US regulatory agency inspections
Benefits
401(k) plan with generous employer match
12 weeks of paid parental leave
Up to 12 weeks of living organ and bone marrow leave
Equity incentive plans
Health plans (medical, prescription drug, dental, and vision)
Life insurance and disability
Flexible time off
Annual Winter Holiday shut down
At least 11 paid holidays
Company
Ardelyx, Inc.
Ardelyx was founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs.
Funding
Current Stage
Public CompanyTotal Funding
$557.68MKey Investors
HealthCare Royalty PartnersSLR Capital PartnersNew Enterprise Associates
2022-06-30Post Ipo Debt· $20M
2022-02-24Post Ipo Debt· $27.5M
2019-12-12Post Ipo Equity· $125M
Recent News
New Enterprise Associates
2025-12-02
2025-11-21
Company data provided by crunchbase